Ouro Fino Saude Animal Participacoes SA OFSA3
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- BRL 21.50
- Day Range
- BRL 21.06–21.87
- 52-Week Range
- BRL 18.20–27.01
- Bid/Ask
- BRL 0.00 / BRL 0.00
- Market Cap
- BRL 1.15 Bil
- Volume/Avg
- 2,200 / 7,707
Key Statistics
- Price/Earnings (Normalized)
- 22.68
- Price/Sales
- 1.21
- Dividend Yield (Trailing)
- 1.29%
- Dividend Yield (Forward)
- 1.57%
- Total Yield
- 1.58%
Company Profile
Ouro Fino Saude Animal Participacoes SA is engaged in the production and sale of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses and goats and pets. The company reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,201
Comparables
Valuation
|
Metric
|
OFSA3
|
002696
|
600195
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.68 | 201.04 | 32.30 |
Price/Book Value | 1.68 | 1.18 | 1.63 |
Price/Sales | 1.21 | 0.61 | 1.67 |
Price/Cash Flow | 20.82 | 5.85 | 18.20 |
Price/Earnings
OFSA3
002696
600195
Financial Strength
|
Metric
|
OFSA3
|
002696
|
600195
|
|---|---|---|---|
Quick Ratio | 2.64 | 1.20 | 1.84 |
Current Ratio | 3.56 | 1.65 | 2.66 |
Interest Coverage | 2.41 | −0.42 | 16.81 |
Quick Ratio
OFSA3
002696
600195
Profitability
|
Metric
|
OFSA3
|
002696
|
600195
|
|---|---|---|---|
Return on Assets (Normalized) | 3.88% | 0.36% | 3.32% |
Return on Equity (Normalized) | 7.31% | 0.75% | 5.13% |
Return on Invested Capital (Normalized) | 6.76% | 1.37% | 4.00% |
Return on Assets
OFSA3
002696
600195
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xscsjyzwv | Jyrkh | $72.8 Bil | |
MKKGY
| Merck KGaA ADR | Vksxfdcxqp | Tzdqkrf | $69.4 Bil | |
HLN
| Haleon PLC ADR | Bnjsyfrl | Fggc | $38.9 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Bfszrqq | Hygrx | $15.9 Bil | |
VTRS
| Viatris Inc | Rxmlkvmr | Mhsq | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Glnmhnxz | Ncnp | $12.4 Bil | |
CTLT
| Catalent Inc | Yrfbvfcxc | Pthpln | $10.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Sscsvhdzj | Lmtww | $4.6 Bil | |
PRGO
| Perrigo Co PLC | Fyvfjjrj | Ppk | $4.4 Bil | |
GTBIF
| Green Thumb Industries Inc | Lptzvckkh | Mtjb | $3.7 Bil |